CNBX Pharmaceuticals Inc.
CNBX Pharmaceuticals Inc. (CNBX): 9 pipeline candidates · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
1.3 months
0% dilution
Lead: Preclinical
9 candidates
N/A
N/A
A transparent, data-derived signal for CNBX Pharmaceuticals Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$245K
Cash
$12K
Quarterly Burn
$31K
Runway
1.3 mo
Revenue
$0
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (9 candidates)
| Drug | Phase |
|---|---|
| BRST-33 | Preclinical |
| Cannabics CDx | Preclinical |
| Cannabics SR | Preclinical |
| MLN-33 | Preclinical |
| Np-01 | Preclinical |
| NP-02 | Preclinical |
| PLP-33 | Preclinical |
| PRST-33 | Preclinical |
| RCC-33 | Preclinical |
Institutional Holdings
Source: SEC Form 13F · as of Sep 2024Institutional holders
1
Total value held
$0
| Holder | Shares | Value |
|---|---|---|
| archer investment corp | 9 | $0 |
Frequently asked questions
How many drug candidates are in CNBX Pharmaceuticals Inc.'s pipeline?
CNBX Pharmaceuticals Inc. (CNBX) has 9 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is CNBX Pharmaceuticals Inc.'s lead drug candidate?
CNBX Pharmaceuticals Inc.'s most advanced tracked candidate is BRST-33 (Preclinical) for Treatment of breast cancer.
What is CNBX Pharmaceuticals Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, CNBX Pharmaceuticals Inc. has approximately 1.3 months of cash runway.
What is CNBX Pharmaceuticals Inc.'s market capitalization?
CNBX Pharmaceuticals Inc.'s market capitalization is approximately $245K.
Who is the CEO of CNBX Pharmaceuticals Inc.?
Mr. Eyal Barad is the chief executive officer of CNBX Pharmaceuticals Inc. (CNBX).
Get the full picture on CNBX Pharmaceuticals Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.